Phathom Pharmaceuticals Inc (PHAT) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 14.07%84.72 | 74.27 | 58.30 | 57.58 | 49.50 |
| Cost Of Revenue | 21.67%18.37 | 15.10 | 12.00 | 7.65 | 6.19 |
| Gross Profit | 12.13%66.36 | 59.18 | 46.31 | 49.94 | 43.31 |
5.22%66.44 | 63.14 | 61.78 | 55.86 | 58.59 | |
| Selling, General, and Administrative | 4.27%57.70 | 55.33 | 54.01 | 48.37 | 51.56 |
| Research and Development | 11.93%8.75 | 7.81 | 7.77 | 7.49 | 7.03 |
| Operating Income/Loss | 97.86%-0.09 | -3.97 | -15.48 | -5.93 | -15.27 |
| Nonoperating Income/Loss | 1.43%-13.81 | -13.62 | -14.89 | -15.22 | -14.70 |
20.96%-13.90 | -17.58 | -30.37 | -21.15 | -29.97 | |
| Attributable To Parent | 20.96%-13.90 | -17.58 | -30.37 | -21.15 | -29.97 |
| Basic Average Shares | 1.37%84.89 | 83.75 | 82.05 | 0.30 | 73.40 |
| Diluted Average Shares | 1.37%84.89 | 83.75 | 82.05 | 0.30 | 73.40 |
| Basic Earnings Per Share | 23.81%-0.16 | -0.21 | -0.37 | -0.27 | -0.41 |
| Diluted Earnings Per Share | 23.81%-0.16 | -0.21 | -0.37 | -0.27 | -0.41 |